A step towards precision medicine in management of severe transient polyhydramnios: MAGED2 variant

J Obstet Gynaecol. 2019 Apr;39(3):395-397. doi: 10.1080/01443615.2018.1454415. Epub 2018 Jun 12.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adaptor Proteins, Signal Transducing / blood
  • Antigens, Neoplasm / blood
  • Bartter Syndrome / genetics*
  • Bartter Syndrome / therapy
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases / genetics*
  • Male
  • Mutation
  • Pedigree
  • Polyhydramnios / genetics*
  • Polyhydramnios / therapy
  • Pregnancy
  • Young Adult

Substances

  • Adaptor Proteins, Signal Transducing
  • Antigens, Neoplasm
  • MAGED2 protein, human